Waldencast (NASDAQ:WALD - Get Free Report) is expected to be posting its Q1 2025 quarterly earnings results before the market opens on Tuesday, May 13th. Analysts expect the company to announce earnings of ($0.11) per share and revenue of $68.27 million for the quarter.
Waldencast Stock Up 4.4 %
WALD stock traded up $0.12 during midday trading on Friday, hitting $2.82. The stock had a trading volume of 39,485 shares, compared to its average volume of 124,855. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.47 and a quick ratio of 0.78. The business has a 50-day moving average of $2.86 and a two-hundred day moving average of $3.22. Waldencast has a 52-week low of $2.31 and a 52-week high of $5.21.
Analyst Upgrades and Downgrades
WALD has been the topic of a number of research analyst reports. Telsey Advisory Group restated an "outperform" rating and issued a $5.00 price target on shares of Waldencast in a report on Tuesday, May 6th. DA Davidson reissued a "buy" rating and issued a $7.50 price objective on shares of Waldencast in a report on Wednesday, March 19th. Industrial Alliance Securities set a $5.00 price objective on shares of Waldencast in a report on Tuesday, April 22nd. Finally, Alliance Global Partners began coverage on Waldencast in a report on Tuesday, April 22nd. They set a "buy" rating and a $5.00 price objective on the stock. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $5.40.
View Our Latest Report on WALD
Waldencast Company Profile
(
Get Free Report)
Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.
Further Reading
Before you consider Waldencast, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Waldencast wasn't on the list.
While Waldencast currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
